凝固酶陰性葡萄球菌感染的流行病學及耐藥機制研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

張慧芳 ,  王瑞蘭

上海交通大學附屬上海市第一人民醫院危重病科(上海 201620);

Corresponding?author：

王瑞蘭, Email: wangyusun@hotmail.com

Keywords：

DOI：

10.7507/1671-6205.2015076

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 張慧芳, 王瑞蘭. 凝固酶陰性葡萄球菌感染的流行病學及耐藥機制研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2015, 14(3): 307-309. doi: 10.7507/1671-6205.2015076 Copy

1.	?Rogers KL,Fey PD,Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am,2009,23:73-98.
2.	Kloos WE. Natural populations of the genus Staphylococcus. Annu Rev Microbiol,1980,34:559-592.
3.	Kloos WE,Musselwhite MS. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol,1975,30:381-385.
4.	Anday EK,Talbot GH. Coagulase-negative Staphylococcus bacteremia--a rising threat in the newborn infant. Ann Clin Lab Sci,1985,15:246-251.
5.	胡付品,朱德妹,汪復,等.2013年中國CHINET細菌耐藥性監測.中國感染與化療雜志,2014,14:369-378.
6.	Fontela PS,Platt RW,Rocher I,et al. Epidemiology of central line-associated bloodstream infections in Quebec intensive care units:a 6-year review. Am J Infect Control,2012,40:221-226.
7.	歐陽穎,方建培,麥友剛,等.新生兒呼吸機相關性肺炎病原菌變遷及耐藥性分析.中山大學學報,2012,33:644-648.
8.	張本,欒榮生,劉衡川,等.成都地區血漿凝固酶陰性葡萄球菌耐藥性及分子流行病學分析.衛生研究,2006,35:775-780.
9.	Cercenado E. Update of antimicrobial resistance in Gram-positive microorganisms. Med Clin (Barc),2010,135 Suppl 3:10-15.
10.	Nicoletti G,Bonfiglio G,Bartoloni A,et al. Distribution and antibiotic resistance of isolates from lower respiratory tract and blood cultures from patients in three Italian intensive care units:a 2-year comparison. Int J Antimicrob Agents,2000,15:265-269.
11.	Stefani S,Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect,2003,9:1179-1186.
12.	Rosenthal EJ. Epidemiology of septicaemia pathogens. Dtsch Med Wochenschr,2002,127:2435-2440.
13.	Tornero E,Garcia-Oltra E,Garcia-Ramiro S,et al. Prosthetic joint infections due to Staphylococcus aureus and coagulase-negative staphylococci. Int J Artif Organs,2012,35:884-892.
14.	Cremniter J,Slassi A,Quincampoix JC,et al. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections. J Clin Microbiol,2010,48:1428-1431.
15.	Licking E. Getting a grip on bacterial slime. Business week,1999,78-79.
16.	Farina N,Carpinelli L,Samudio M,et al. Clinically significant coagulase-negative staphylococci:most frequent species and virulence factors. Rev Chilena Infectol,2013,30:480-488.
17.	Mack D,Rohde H,Harris LG,et al. Biofilm formation in medical device-related infection. Int J Artif Organs,2006,29:343-359.
18.	Girard LP,Ceri H,Gibb AP,et al. MIC versus MBEC to determine the antibiotic sensitivity of Staphylococcus aureus in peritoneal dialysis peritonitis. Perit Dial Int,2010,30:652-656.
19.	Ojo SK,Sargin BO,Esumeh FI. Plasmid curing analysis of antibiotic resistance in beta-lactamase producing Staphylococci from wounds and burns patients. Pak J Biol Sci,2014,17:130-133.
20.	Wang Y,He T,Schwarz S,et al. Multidrug resistance gene cfr in methicillin-resistant coagulase-negative staphylococci from chickens,ducks,and pigs in China. Int J Med Microbiol,2013,303:84-87.
21.	Cui L,Wang Y,Li Y,et al. Cfr-mediated linezolid-resistance among methicillin-resistant coagulase-negative staphylococci from infections of humans. PLoS One,2013,8:e57096.
22.	Tomasz A,Nachman S,Leaf H. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother,1991,35:124-129.
23.	Casapao AM,Leonard SN,Davis SL,et al. Clinical outcomes in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bloodstream infection. Antimicrob Agents Chemother,2013,57:4252-4259.
24.	Park YJ,Jun Park J,Lee SO,et al. Low-level resistance to glycopeptides amongst staphylococcus species:surveillance in a university hospital and evaluation of a vancomycin screening agar. Diagn Microbiol Infect Dis,2001,41:155-159.
25.	van den Braak N,van Belkum A,te Witt R,et al. Glycopeptide resistance amongst Staphylococcus spp. J Antimicrob Chemother,1998,42:673-675.
26.	Sieradzki K,Villari P,Tomasz A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother,1998,42:100-107.
27.	Biavasco F,Vignaroli C,Lazzarini R,et al. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates. Antimicrob Agents Chemother,2000,44:3122-3126.
28.	Harbarth S,Sax H,Gastmeier P. The preventable proportion of nosocomial infections:an overview of published reports. J Hosp Infect,2003,54:258-266.

1. ?Rogers KL,Fey PD,Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am,2009,23:73-98.
2. Kloos WE. Natural populations of the genus Staphylococcus. Annu Rev Microbiol,1980,34:559-592.
3. Kloos WE,Musselwhite MS. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol,1975,30:381-385.
4. Anday EK,Talbot GH. Coagulase-negative Staphylococcus bacteremia--a rising threat in the newborn infant. Ann Clin Lab Sci,1985,15:246-251.
5. 胡付品,朱德妹,汪復,等.2013年中國CHINET細菌耐藥性監測.中國感染與化療雜志,2014,14:369-378.
6. Fontela PS,Platt RW,Rocher I,et al. Epidemiology of central line-associated bloodstream infections in Quebec intensive care units:a 6-year review. Am J Infect Control,2012,40:221-226.
7. 歐陽穎,方建培,麥友剛,等.新生兒呼吸機相關性肺炎病原菌變遷及耐藥性分析.中山大學學報,2012,33:644-648.
8. 張本,欒榮生,劉衡川,等.成都地區血漿凝固酶陰性葡萄球菌耐藥性及分子流行病學分析.衛生研究,2006,35:775-780.
9. Cercenado E. Update of antimicrobial resistance in Gram-positive microorganisms. Med Clin (Barc),2010,135 Suppl 3:10-15.
10. Nicoletti G,Bonfiglio G,Bartoloni A,et al. Distribution and antibiotic resistance of isolates from lower respiratory tract and blood cultures from patients in three Italian intensive care units:a 2-year comparison. Int J Antimicrob Agents,2000,15:265-269.
11. Stefani S,Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect,2003,9:1179-1186.
12. Rosenthal EJ. Epidemiology of septicaemia pathogens. Dtsch Med Wochenschr,2002,127:2435-2440.
13. Tornero E,Garcia-Oltra E,Garcia-Ramiro S,et al. Prosthetic joint infections due to Staphylococcus aureus and coagulase-negative staphylococci. Int J Artif Organs,2012,35:884-892.
14. Cremniter J,Slassi A,Quincampoix JC,et al. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections. J Clin Microbiol,2010,48:1428-1431.
15. Licking E. Getting a grip on bacterial slime. Business week,1999,78-79.
16. Farina N,Carpinelli L,Samudio M,et al. Clinically significant coagulase-negative staphylococci:most frequent species and virulence factors. Rev Chilena Infectol,2013,30:480-488.
17. Mack D,Rohde H,Harris LG,et al. Biofilm formation in medical device-related infection. Int J Artif Organs,2006,29:343-359.
18. Girard LP,Ceri H,Gibb AP,et al. MIC versus MBEC to determine the antibiotic sensitivity of Staphylococcus aureus in peritoneal dialysis peritonitis. Perit Dial Int,2010,30:652-656.
19. Ojo SK,Sargin BO,Esumeh FI. Plasmid curing analysis of antibiotic resistance in beta-lactamase producing Staphylococci from wounds and burns patients. Pak J Biol Sci,2014,17:130-133.
20. Wang Y,He T,Schwarz S,et al. Multidrug resistance gene cfr in methicillin-resistant coagulase-negative staphylococci from chickens,ducks,and pigs in China. Int J Med Microbiol,2013,303:84-87.
21. Cui L,Wang Y,Li Y,et al. Cfr-mediated linezolid-resistance among methicillin-resistant coagulase-negative staphylococci from infections of humans. PLoS One,2013,8:e57096.
22. Tomasz A,Nachman S,Leaf H. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother,1991,35:124-129.
23. Casapao AM,Leonard SN,Davis SL,et al. Clinical outcomes in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bloodstream infection. Antimicrob Agents Chemother,2013,57:4252-4259.
24. Park YJ,Jun Park J,Lee SO,et al. Low-level resistance to glycopeptides amongst staphylococcus species:surveillance in a university hospital and evaluation of a vancomycin screening agar. Diagn Microbiol Infect Dis,2001,41:155-159.
25. van den Braak N,van Belkum A,te Witt R,et al. Glycopeptide resistance amongst Staphylococcus spp. J Antimicrob Chemother,1998,42:673-675.
26. Sieradzki K,Villari P,Tomasz A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother,1998,42:100-107.
27. Biavasco F,Vignaroli C,Lazzarini R,et al. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates. Antimicrob Agents Chemother,2000,44:3122-3126.
28. Harbarth S,Sax H,Gastmeier P. The preventable proportion of nosocomial infections:an overview of published reports. J Hosp Infect,2003,54:258-266.

Previous Article
半乳甘露聚糖實驗診斷曲霉病的進展
Next Article
支氣管哮喘癥狀控制水平與感知水平差異性及其影響因素分析

Chinese Journal of Respiratory and Critical Care Medicine

凝固酶陰性葡萄球菌感染的流行病學及耐藥機制研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content